American Vietnamese Biotech (HSTC:AMV) Total Receivables: ₫0.00 Mil (As of . 20)


What is American Vietnamese Biotech Total Receivables?

American Vietnamese Biotech HSTC:AMV Total Receivables is ₫0.00 Mil as of . 20.

American Vietnamese Biotech's Total Receivables for the quarter that ended in . 20 was ₫0.00 Mil.

American Vietnamese Biotech Total Receivables Related Terms

American Vietnamese Biotech Total Receivables Historical Data

* Premium members only.

The historical data trend for American Vietnamese Biotech's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

American Vietnamese Biotech Total Receivables Chart

American Vietnamese Biotech Annual Data
Trend
Total Receivables

American Vietnamese Biotech Quarterly Data
Total Receivables

American Vietnamese Biotech Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of ₫0.00 Mil mean?
American Vietnamese Biotech (HSTC:AMV) has a Total Receivables of ₫0.00 Mil as of . 20. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on American Vietnamese Biotech and its competitors.
Is American Vietnamese Biotech's Total Receivables too high?
American Vietnamese Biotech's current Total Receivables is ₫0.00 Mil.
How does American Vietnamese Biotech's Total Receivables compare to HSTC and STLT?
American Vietnamese Biotech's Total Receivables of ₫0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Biotechnology company?
A good Total Receivables depends on the Biotechnology industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on American Vietnamese Biotech and its competitors. American Vietnamese Biotech's current Total Receivables is ₫0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is American Vietnamese Biotech stock overvalued right now?
American Vietnamese Biotech (HSTC:AMV) has a current Total Receivables of ₫0.00 Mil. The current Total Receivables is ₫0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For American Vietnamese Biotech (HSTC:AMV), the current Total Receivables is ₫0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

American Vietnamese Biotech Business Description

Address No. 85 Hoang Van Thai, 4th Floor, Phu Ma Duong Building, Tan Phu Ward, District 7, Ho Chi Minh, VNM
American Vietnamese Biotech Incorporation is engaged in trading in pharmaceuticals, purchasing and selling medical equipment, medical testing instruments, and chemicals; producing and trading vaccines and medical biological products.